Submitted by Anonymous (not verified) on 13 November 2023 - 16:20
Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 21/11/2014, Revision: 18, Status: Authorised
Source: